EXO ACTIVATE Follicle Enrichment Serum

Route: Topical scalp application.

Apply directly to the scalp in areas of concern. Gently massage the serum into the scalp using fingertips to promote penetration and local microcirculation. For enhanced dermal delivery, application following microneedling or dermaroller treatment (as directed by the clinician) may be recommended. Avoid contact with eyes. Do not rinse out immediately; allow the serum to absorb. Apply as directed by the prescribing clinician.

Application frequency and protocol are prescriber-determined based on the clinical context and any concurrent procedural treatments. Typical practice:

• Apply once daily or several times per week to affected scalp areas, as directed.
• Consistent use over a minimum of 3–6 months is generally recommended before evaluating follicular response.
• Application timing relative to any microneedling, laser, or PRP procedures should be coordinated with the treating clinician.

Extracellular vesicles (exosomes) are lipid bilayer-enclosed nanoparticles secreted by multiple cell types. When applied topically to the scalp (optimally after microneedling or similar barrier disruption to enhance penetration), they are internalized by dermal papilla cells, follicular keratinocytes, and scalp fibroblasts via endocytosis. Once internalized, the vesicle cargo — including growth factors, miRNAs, and signaling proteins — modulates recipient cell gene expression:

• Growth factors such as VEGF promote scalp angiogenesis and nutrient delivery to the follicular bulb.
• KGF (keratinocyte growth factor/FGF-7) and IGF-1 signaling support follicular keratinocyte proliferation and anagen maintenance.
• Anti-inflammatory miRNAs and cytokines reduce scalp inflammation (IL-6, TNF-α), which can contribute to follicular miniaturization.
• miRNA cargo may downregulate pro-apoptotic and catagen-promoting pathways, extending the anagen growth phase.

Clinical Context: EXO ACTIVATE is intended for prescriber-directed use as part of a hair restoration protocol for patients with androgenetic alopecia, alopecia areata, or other forms of non-scarring hair thinning. Exosome-based scalp therapies represent an emerging class of regenerative agents in aesthetic medicine; current evidence derives primarily from preclinical and early clinical studies. This product is complementary to, not a replacement for, established evidence-based treatments (e.g., minoxidil, finasteride, PRP therapy).

Monitoring Considerations:

• Assess follicular density, hair thickness, and patient-reported outcomes at 3-month intervals using standardized photography or trichoscopy.
• Document baseline and follow-up parameters to evaluate clinical trajectory.
• Coordinate with any concurrent alopecia treatments in the patient's overall management plan.

Contraindications:

• Known hypersensitivity to any component of the serum.
• Active scalp infection, open scalp wounds, or active inflammatory scalp dermatosis in the application area (defer application until resolved).

Warnings & Precautions:

• This preparation is for external topical scalp use only. Avoid ocular and mucosal contact.
• Exosome-based preparations are an emerging area of medicine; long-term safety data from large controlled trials are limited. Use should be in the context of prescriber oversight.
• The regulatory status of exosome products is evolving; prescribers should stay current with FDA guidance on cell-derived and exosome-based preparations.

Drug Interactions:

• No established pharmacokinetic drug interactions. Avoid combining with scalp preparations that create a strongly oxidizing or highly acidic environment in the same application session, which may degrade vesicle integrity.

Common Side Effects: Generally well tolerated. Mild transient scalp erythema, tingling, or pruritus may occur, particularly following microneedling-assisted delivery.

Store as directed on the prescription label. Exosome/extracellular vesicle preparations are typically refrigerated (2–8°C / 36–46°F) to maintain vesicle integrity and bioactivity. Protect from light. Do not freeze. Bring to room temperature before application if instructed. Keep out of reach of children. Use before the beyond-use date (BUD) assigned by Genesis Compounding.

What are exosomes and how do they support hair follicles?

Exosomes are tiny vesicles (30–120 nm) naturally secreted by cells to carry molecular signals — growth factors, RNA, and proteins — between cells. When applied to the scalp, they deliver these regenerative signals to hair follicle cells, supporting the growth phase and follicular health.

Do I need microneedling for this to work?

Microneedling is not strictly required, but it significantly enhances penetration of the serum through the scalp's outer barrier, allowing greater delivery to the dermal papilla where follicular signaling occurs. Your prescriber will advise whether microneedling is part of your protocol.

Is this an FDA-approved hair loss treatment?

No. This is a 503A compounded preparation made by Genesis Compounding per prescriber order. Exosome-based preparations are an emerging area; they are not FDA-approved as drug products. They are used in clinical practice as part of individualized, prescriber-directed protocols.

How long until I see results?

Hair follicle cycling occurs over months, and regenerative therapies require consistent application over 3–6 months before meaningful clinical change can be assessed. Standardized photography at baseline and follow-up intervals helps track response.

Can I use this alongside minoxidil or finasteride?

Exosome scalp serums are generally used as adjuncts to, not replacements for, pharmacological treatments like minoxidil or finasteride. Your prescriber will coordinate a comprehensive hair restoration plan that integrates all relevant treatments appropriately.